Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Bernhard

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
The Journal of Pharmacology and Experimental Therapeutics|November 26, 2009
The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenaseAndreas Koeberle, Antonietta Rossi, Heiko Zettl, et al.
Free Radical Biology & Medicine|April 26, 2022
The F2-isoprostane 8-iso-PGF<sub>2α</sub> attenuates atherosclerotic lesion formation in Ldlr-deficient mice - Potential role of vascular thromboxane A<sub>2</sub> receptorsHeike Braun, Michael Hauke, Robert Eckenstaler, et al.
Angewandte Chemie (International Ed. in English)|August 14, 2020
The Conformational Equilibrium of the Neuropeptide Y2 Receptor in Bilayer MembranesUlrike Krug, Anika Gloge, Peter Schmidt, et al.
Biochemical Pharmacology|November 18, 2023
Deletion of vascular thromboxane A<sub>2</sub> receptors and its impact on angiotensin II-induced hypertension and atherosclerotic lesion formation in the aorta of Ldlr-deficient miceHeike Braun, Michael Hauke, Markus Petermann, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 13, 2022
Electroneutral Polymer Nanodiscs Enable Interference-Free Probing of Membrane Proteins in a Lipid-Bilayer EnvironmentDavid Glueck, Anne Grethen, Manabendra Das, et al.
STAR Protocols|November 2, 2023
A concise guide to choosing suitable gene expression systems for recombinant protein productionAnja Schütz, Frank Bernhard, Nick Berrow, et al.
European Journal of Epidemiology|January 3, 2022
Cardiovascular risk factors, living and ageing in Halle: the CARLA studyLamiaa Hassan, Ljupcho Efremov, Anne Großkopf, et al.
Cancers|March 25, 2022
Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO)Sabrina Jotschke, Susann Schulze, Nadja Jaekel, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
The Journal of Pharmacology and Experimental Therapeutics|November 26, 2009
The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenaseAndreas Koeberle, Antonietta Rossi, Heiko Zettl, et al.
Free Radical Biology & Medicine|April 26, 2022
The F2-isoprostane 8-iso-PGF<sub>2α</sub> attenuates atherosclerotic lesion formation in Ldlr-deficient mice - Potential role of vascular thromboxane A<sub>2</sub> receptorsHeike Braun, Michael Hauke, Robert Eckenstaler, et al.
Angewandte Chemie (International Ed. in English)|August 14, 2020
The Conformational Equilibrium of the Neuropeptide Y2 Receptor in Bilayer MembranesUlrike Krug, Anika Gloge, Peter Schmidt, et al.
Biochemical Pharmacology|November 18, 2023
Deletion of vascular thromboxane A<sub>2</sub> receptors and its impact on angiotensin II-induced hypertension and atherosclerotic lesion formation in the aorta of Ldlr-deficient miceHeike Braun, Michael Hauke, Markus Petermann, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 13, 2022
Electroneutral Polymer Nanodiscs Enable Interference-Free Probing of Membrane Proteins in a Lipid-Bilayer EnvironmentDavid Glueck, Anne Grethen, Manabendra Das, et al.
STAR Protocols|November 2, 2023
A concise guide to choosing suitable gene expression systems for recombinant protein productionAnja Schütz, Frank Bernhard, Nick Berrow, et al.
European Journal of Epidemiology|January 3, 2022
Cardiovascular risk factors, living and ageing in Halle: the CARLA studyLamiaa Hassan, Ljupcho Efremov, Anne Großkopf, et al.
Cancers|March 25, 2022
Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO)Sabrina Jotschke, Susann Schulze, Nadja Jaekel, et al.
Pageof 13